Latest News about SNY
Recent news which mentions SNY
From Benzinga
 
   Sanofi Adds Acne Vaccine Candidate Via Origimm Biotechnology Acquisition
   
  
  
  December 01, 2021
  From Benzinga
 From Benzinga
 
   1 Cancer Stock on Buyout Watch in 2022
   
  
  
  November 21, 2021
  From Motley Fool
 
   What Are the Top COVID Plays for 2022?
   
  
  
  November 19, 2021
  From Motley Fool
 
   Why Connect Biopharma Stock Is Crashing Today
   
  
  
  November 19, 2021
  From Motley Fool
 
   The Daily Biotech Pulse: Connect Biopharma Sinks On Eczema Drug Readout, Enanta Pulls Plug On HBV Drug, Clinical Setback For Merck In HIV Trial
   
  
  
  November 19, 2021
  From Benzinga
 
   These 3 High-Yield Dividend Stocks Are Growing at Blazing Speeds
   
  
  
  November 18, 2021
  From Motley Fool
 
   3 Top Biotech Stocks to Buy Right Now
   
  
  
  November 13, 2021
  From Motley Fool
 
   A Pfizer Drug Moves Closer to Approval in Another Important Indication
   
  
  
  November 02, 2021
  From Motley Fool
 
   The Daily Biotech Pulse: Gilead-Merck Collaborate For Breast Cancer Study, Decision Day For ANI Pharma, Pfizer Gets Canadian Regulatory Nod, 3 IPOs
   
  
  
  October 29, 2021
  From Benzinga
 
   Earnings Scheduled For October 28, 2021
   
  
  
  October 28, 2021
  From Benzinga
 
   The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More
   
  
  
  October 24, 2021
  From Benzinga
 From Benzinga
 
   If I Could Only Own 1 Healthcare Stock, This Is What It Would Be
   
  
  
  October 21, 2021
  From Motley Fool
 
   The Daily Biotech Pulse: FDA Authorizes Moderna, J&J Booster Shots; Regulatory Approvals For Bristol-Myers Squibb, Sanofi-Regeneron; Ventyx IPO
   
  
  
  October 21, 2021
  From Benzinga
 
   2 Stocks That Could Grow Your Portfolio Over the Next Decade
   
  
  
  October 20, 2021
  From Motley Fool
 From Motley Fool
 
   The Week Ahead In Biotech (Oct. 18-23): J&J, Biogen Kickstart Big Pharma Earnings, Regeneron-Sanofi, Roche Await FDA Decisions And IPOs
   
  
  
  October 18, 2021
  From Benzinga
 
   2 Top Healthcare Stocks That Could Be Bought Out in 2022
   
  
  
  October 16, 2021
  From Motley Fool
 
   3 No-Brainer Biotech Stocks to Buy Right Now
   
  
  
  October 16, 2021
  From Motley Fool
 
   Tech Sell-Off: 2 Unstoppable Stocks to Buy Now
   
  
  
  October 14, 2021
  From Motley Fool
 
   Pfizer Just Scored Another Key Regulatory Approval
   
  
  
  October 14, 2021
  From Motley Fool
 
   Got $5,000? 3 Top Dividend Stocks to Buy Right Now
   
  
  
  October 13, 2021
  From Motley Fool
 
   3 Biotech Stocks You Can Buy and Hold for the Next Decade
   
  
  
  October 13, 2021
  From Motley Fool
 From MarketWatch
 
   Regeneron Could Have a Big Catalyst Coming in 2022
   
  
  
  October 09, 2021
  From Motley Fool
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.